SELECTED PUBLICATIONS
- Ni X, Castanares M, Mukherjee A, and Lupold SE. Nucleic
Acid Aptamer: clinical applications and promising new
horizons. Cur Med Chem. 18(27), 4206-4214, 2011
-
Ni X, Zhang Y, Ribas J, Chowdhury WH, Castanares M, Zhang
Z, Laiho M, DeWeese TL, Lupold SE. Prostate-targeted
radiosensitization via aptamer-shRNA chimeras in human
tumor xenografts. Journal of Clinical Investigation. J
Clin Invest. 2011 Jun 1;121(6):2383-90.
-
Wu P, Kudrolli TA, Chowdhury WH, Minzhi ML, Rodriguez R,
and Lupold SE. Adenovirus Targeting to Prostate-specific
Membrane Antigen through Virus displayed Semi-random
Peptide Library Screening. [Priority Report] Cancer Res. 2010 Dec 1;70(23):9549-53.
-
Ribas J and Lupold SE. The transcriptional regulation of
miR-21, its multiple transcripts, and their implication in
prostate cancer. Cell Cycle; 9(5), 923-9, 2010
-
Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi1 AH,
Chowdhury WE, Kudrolli TA, Yegnasubramanian A, Luo J,
Rodriguez T, Mendell JT, Lupold SE. miR-21: An androgen
receptor regulated microRNA which promotes hormone
dependent and independent prostate cancer growth. Cancer
Research. [Priority Report] 69(18): 7165-9, 2009
-
Lupold SE., Kudrolli T., Chowdhury W., Wu P, and Rodriguez
R. "A Novel Method for Generating and Screening Peptides
and Libraries Displayed on Adenovirus Fiber" Nucl. Acids
Res. 35(20):e138, 1-10, 2007
-
Lupold SE, Rodriguez R. "Adenoviral Vectors for Prostate
Cancer Gene Therapy" Cancer Therapy, Vol 3, 267-284, 2005
-
Lupold SE, Rodriguez R. "Adenoviral Gene Therapy,
Radiation, and Prostate Cancer" Reviews in Urology; Vol
7(4), 193-202. Fall 2005
-
Lupold SE., Rodriguez R. Disulfide-Constrained Peptides
that Bind to the Extracellular Portion of the Prostate
Specific Membrane Antigen. Mol Cancer Ther. 3(5):597-603,
2004
-
Lupold SE., Hicke B.J., Lin Y., Coffey DS. Identification
and characterization of nuclease-stabilized RNA molecules
that bind human prostate cancer cells via the
prostate-specific membrane antigen. Cancer Research. 62(14):4029-33, 2002.
BOOK CHAPTERS
- Byun Y, Mease RC, Lupold SE, Pomper MG. Recent Development of Diagnostic and Therapeutic Agents Targeting Glutamate Carboxypeptidase II (GCPII), Chapter 36, In Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications. Wiley, 2009
OTHER MEDIA
- Lupold SE. Molecular Approaches to Prostate Cancer, Johns Hopkins Medicine Podcast, 2008
|
